N/A
Completed N=306
Ending Transmission of HIV, HCV, and STDs and Overdose in Rural Communities of People Who Inject Drugs (ETHIC)
Source: ClinicalTrials.gov NCT04427202 ↗Enrolled (actual)
306
Serious AEs
1.6%
Results posted
Dec 2024
Primary outcomePrimary: Total Participants Who Received Referrals to the Harm Reduction Services Organization — 121 Participants
Summary
This study will evaluate the referral to harm reduction services (HRS) including syringe services, naloxone overdose prevention, substance use treatment referral, HIV, HCV, and STD testing and referral and linkage to care through capacity building of existing programs through client services data.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Total Participants Who Received Referrals to the Harm Reduction Services Organization |
121 | — |
| SECONDARY Number of Locations Where Participants Received Most of Syringes or Needles |
92 | — |
| SECONDARY Number of Times Sterile Syringes and/or Equipment Obtained From an Intervention |
2.5 | — |
| SECONDARY Number of Times Participants Used a Syringe or Needle That They Knew Was Used by Somebody Else |
0.9 | — |
| SECONDARY Number of Times Participants Used a Cotton, Cooker, Spoon, or Water for Rinsing or Mixing That They Knew Was Used by Somebody Else |
2.5 | — |
| SECONDARY Number of Times Participants Let Someone Else Use a Cotton, Cooker, Spoon, or Water for Rinsing or Mixing After They Used it |
2.3 | — |
| SECONDARY Number of Participants With Drive Time Less Than 30 Minutes to Nearest Syringe or Needle Exchange |
148 | — |
| SECONDARY Number of Participants That Currently Have Naloxone |
93 | — |
| SECONDARY Number of Participants Who Received Substance Use Disorders (SUD) Treatment Referrals |
102 | — |
| SECONDARY Total Number of Participants Who Received an HIV Screening |
288 | — |
| SECONDARY Total Number of Participants Who Received an HCV Screening |
213 | — |
| SECONDARY Number of Participants With Knowledge of PrEP |
155 | — |
| SECONDARY Number of Participants Diagnosed With HIV Who Have Access to HIV Care |
— | — |
| SECONDARY Number of Participants Diagnosed With HCV Who Have Access to HCV Care |
11 | — |
| SECONDARY Number of Times a Participant Engaged in Condomless Sex (Vaginal or Anal) |
9.9 | — |
Eligibility Criteria
Inclusion Criteria
- 15 years of age and older
- Injected any drug in the past 30 days
- Used any opioids non-medically in the past 30 days
- English speaking
- Able to provide informed consent at the time of the study visit
Exclusion Criteria
- Less than 15 years of age
- Not injected any drug in the past 30 days
- Not used any opioids non-medically in past 30 days
- Non-English speaking
- Has not injected any opioid drug to get high in the past 30 days
- Unable to provide informed consent at the time of the study visit
Data sourced from ClinicalTrials.gov (NCT04427202). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.